Switzer TV

In this week’s Switzer Investing TV, Paul Rickard sits down with chartist and market analyst Mike Gable to break down the big ideas driving today’s bull market — from rare earths and uranium to the comeback stories in healthcare and banking.

They look at what’s powering the ASX200’s latest rally, whether the US market still has room to run, and which sectors could surprise next. Plus, Gable shares how he’s positioning in gold, why CSL might finally be turning the corner, and where he sees upside in Macquarie.

In this episode:

• The ASX200’s breakout — sustainable or overdone?

• Rare earths vs lithium: is history repeating?

• Uranium and gold: the commodities back in focus

• Has CSL bottomed, and what’s next for healthcare?

• The banks and Macquarie — are they about to run again?

If you’re looking for market insight that blends technical charts with fundamental reasoning, this is a must-watch for every Australian investor.

Hosted by Paul Rickard | Guest: Mike Gable, Managing Director, Fairmont Equities.

Switzer Investing TV | 20 Oct 2025: Are rare earths about to get the Lithium hosing? Plus: Can US shares run even higher, and will the ASX200 follow?

We break down the big ideas driving today’s bull market: from rare earths and uranium to the comeback stories in healthcare and banking.

More videos

Mad about Money Live

Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.

Series:
3 hot value stocks + CEO of iSelect, buy or not & house price boom to die?

Roger Montgomery from Montgomery Investment Management, Warren Hebard from iSelect, Michael Knox from Morgans and Paul Rickard from Switzer join the show.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for the latest live episode of Mad about Money.

Series:
It’s time to hunt for value stocks, try these: CSL, RMD, BHP, WPL + BHP a buy?

Peter Switzer speaks to Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard from Switzer.

Series:
Basal cancer and the treatments that have risen due to COVID-19

Dr Ross Walker discusses research on basal cell cancer treatment that is similar to the COVID-19 vaccine.

Series:
6 top stocks from fund manager and broker + house price boom exaggerated?

Prime Value Asset Management's ST Wong, Morgans' Raymond Chan, Century 21's Charles Tarbey and Coolabah Capital's Ying Yi Ann Cheng join Peter Switzer.

Series:
Mad about Money Live

Peter Switzer and Paul Rickard discuss the big money stories of the day and how they will affect you.

Series:
Graham Kelly from Noxopharm Limited (ASX:NOX)

Peter Switzer speaks to Graham Kelly, the founder, CEO and managing director of Noxopharm (NOX).

Series:
Stocks being dumped that are long term buys: CSL, DMP, JBH & 4 great income stocks

Burman Invest's Julia Lee, Tribeca's Jun Bei Liu, Switzer's Paul Rickard and Spacetalk's Mark Fortunatow join the show.

Series:
The benefits of drinking coffee and tea every day

Last week Dr Ross told us what happens when diabetics have coffee and tea every day, but what are the benefits for non-diabetics?

Series:
Hot tech stocks – MP1, NXL + could stocks fall 10%? & CEO of Aussie Home Loan

Peter Switzer is joined by Michael Wayne from Medallion Financial Group, Kieran Davies from Coolabah Capital and James Symond from Aussie Home Loans.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for our latest live episode of Mad about Money.

Series:
1 33 34 35 36 37 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram